dc.contributor.author
Lin, Xiaoyuan
dc.contributor.author
Sha, Zhou
dc.contributor.author
Zhang, Chunlin
dc.contributor.author
Adler, Julia M.
dc.contributor.author
Vidal, Ricardo Martin
dc.contributor.author
Langner, Christine
dc.contributor.author
Fu, Beibei
dc.contributor.author
Xiong, Yan
dc.contributor.author
Tan, Meng
dc.contributor.author
Jiang, Chen
dc.contributor.author
Zeng, Hao
dc.contributor.author
Zhang, Xiaokai
dc.contributor.author
Li, Qian
dc.contributor.author
Yan, Jingmin
dc.contributor.author
Lu, Xiaoxue
dc.contributor.author
Wang, Shiwei
dc.contributor.author
Mao, Xuhu
dc.contributor.author
Kunec, Dusan
dc.contributor.author
Trimpert, Jakob
dc.contributor.author
Wu, Haibo
dc.contributor.author
Zou, Quanming
dc.contributor.author
Zhu, Zhenglin
dc.date.accessioned
2025-10-29T11:45:48Z
dc.date.available
2025-10-29T11:45:48Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/50059
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-49784
dc.description.abstract
How SARS-CoV-2 Omicron evolved remains obscure. T492I, an Omicron-specific mutation encountered in SARS-CoV-2 nonstructural protein 4 (NSP4), enhances viral replication and alters nonstructural protein cleavage, inferring potentials to drive evolution. Through evolve-and-resequence experiments of SARS-CoV-2 wild-type (hCoV-19/USA/WA-CDC-02982585-001/2020, A) and Delta strains (B.1.617) with or without T492I, this study demonstrates that the NSP4 mutation T492I confers accelerated phenotypic adaption and a predisposition to the emergence of SARS-CoV-2 Omicron-like variants. The T492I-driven evolution results in accelerated enhancement in viral replication, infectivity, immune evasion capacity, receptor-binding affinity and potential for cross-species transmission. Aside from elevated mutation rates and impact on deaminases, positive epistasis between T492I and adaptive mutations could potentially mechanistically facilitate the shifts in mutation spectra and indirectly determines the Omicron-predisposing evolution. These suggest a potentially important role of the driver mutation T492I in the evolution of SARS-CoV-2 Omicron variants. Our findings highlight the existence and importance of mutation-driven predisposition in viral evolution.
en
dc.format.extent
18 Seiten
dc.rights
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
Evolutionary biology
en
dc.subject
Viral evolution
en
dc.subject.ddc
500 Naturwissenschaften und Mathematik::570 Biowissenschaften; Biologie::570 Biowissenschaften; Biologie
dc.title
A single mutation may contribute to accelerated evolution of SARS-CoV-2 toward Omicron
dc.type
Wissenschaftlicher Artikel
dc.date.updated
2025-10-29T07:44:17Z
dcterms.bibliographicCitation.articlenumber
6951
dcterms.bibliographicCitation.doi
10.1038/s41467-025-62300-0
dcterms.bibliographicCitation.journaltitle
Nature Communications
dcterms.bibliographicCitation.number
1
dcterms.bibliographicCitation.volume
16
dcterms.bibliographicCitation.url
https://doi.org/10.1038/s41467-025-62300-0
refubium.affiliation
Veterinärmedizin
refubium.affiliation.other
Institut für Virologie

refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.isPartOf.eissn
2041-1723
refubium.resourceType.provider
DeepGreen